Literature DB >> 15280656

Mammalian DNA methyltransferase 1: inspiration for new directions.

Angela H Ting1, Kam-wing Jair, Hiromu Suzuki, Ray-Whay Chiu Yen, Stephen B Baylin, Kornel E Schuebel.   

Abstract

The role of DNA methyltransferase 1, DNMT1, in human cancer cells has recently been contested. In this setting, DNMT1's function as the sole maintenance methyltransferase was based on the assumption that its biological activity is identical to the mouse homologue. However, the application of recent technological advances, including gene targeting and siRNA mediated ablation studies, has cast doubt on this presumed role. Here, we attempt to shed light on these new data within the context of previous experiments.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15280656

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  10 in total

1.  Regulation of estrogen receptor alpha gene expression in the mouse prefrontal cortex during early postnatal development.

Authors:  Jenne M Westberry; Melinda E Wilson
Journal:  Neurogenetics       Date:  2012-03-29       Impact factor: 2.660

2.  Expression profiling and clinicopathological significance of DNA methyltransferase 1, 3A and 3B in sporadic human renal cell carcinoma.

Authors:  Ming Li; Ying Wang; Yongsheng Song; Renge Bu; Bo Yin; Xiang Fei; Qizhen Guo; Bin Wu
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

3.  Expression of human DNA methyltransferase 1 in colorectal cancer tissues and their corresponding distant normal tissues.

Authors:  Yi-Min Zhu; Qiong Huang; Jie Lin; Yu Hu; Jian Chen; Mao-De Lai
Journal:  Int J Colorectal Dis       Date:  2006-11-09       Impact factor: 2.571

4.  Epigenetic regulation of estrogen receptor alpha gene expression in the mouse cortex during early postnatal development.

Authors:  Jenne M Westberry; Amanda L Trout; Melinda E Wilson
Journal:  Endocrinology       Date:  2009-12-04       Impact factor: 4.736

5.  Panobinostat treatment depletes EZH2 and DNMT1 levels and enhances decitabine mediated de-repression of JunB and loss of survival of human acute leukemia cells.

Authors:  Warren Fiskus; Kate Buckley; Rekha Rao; Aditya Mandawat; Yonghua Yang; Rajeshree Joshi; Yongchao Wang; Ramesh Balusu; Jianguang Chen; Sanjay Koul; Atul Joshi; Sunil Upadhyay; Peter Atadja; Kapil N Bhalla
Journal:  Cancer Biol Ther       Date:  2009-05-18       Impact factor: 4.742

6.  Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human AML cells.

Authors:  Warren Fiskus; Yongchao Wang; Arun Sreekumar; Kathleen M Buckley; Huidong Shi; Anand Jillella; Celalettin Ustun; Rekha Rao; Pravina Fernandez; Jianguang Chen; Ramesh Balusu; Sanjay Koul; Peter Atadja; Victor E Marquez; Kapil N Bhalla
Journal:  Blood       Date:  2009-07-28       Impact factor: 22.113

7.  Consequences of combining siRNA-mediated DNA methyltransferase 1 depletion with 5-aza-2'-deoxycytidine in human leukemic KG1 cells.

Authors:  Stéphane Vispé; Arthur Deroide; Emeline Davoine; Cécile Desjobert; Fabrice Lestienne; Lucie Fournier; Natacha Novosad; Sophie Bréand; Jérôme Besse; Florence Busato; Jörg Tost; Luc De Vries; Didier Cussac; Joëlle Riond; Paola B Arimondo
Journal:  Oncotarget       Date:  2015-06-20

Review 8.  Molecular aspects of development and regulation of endometriosis.

Authors:  Yana B Aznaurova; Marat B Zhumataev; Tiffany K Roberts; Alexander M Aliper; Alex A Zhavoronkov
Journal:  Reprod Biol Endocrinol       Date:  2014-06-13       Impact factor: 5.211

9.  WI-38 senescence is associated with global and site-specific hypomethylation.

Authors:  Corinne Sidler; Rafal Woycicki; Igor Kovalchuk; Olga Kovalchuk
Journal:  Aging (Albany NY)       Date:  2014-07       Impact factor: 5.682

10.  Islet-1 induces the differentiation of mesenchymal stem cells into cardiomyocyte-like cells through the regulation of Gcn5 and DNMT-1.

Authors:  Qin Yi; Hao Xu; Ke Yang; Yue Wang; Bin Tan; Jie Tian; Jing Zhu
Journal:  Mol Med Rep       Date:  2017-03-16       Impact factor: 2.952

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.